%0 Journal Article %T The Society for Translational Medicine: the assessment and prevention of venous thromboembolism after lung cancer surgery %A Li, Hui %A Jiang, Gening %A Bölükbas, Servet %A Chen, Chun %A Chen, Haiquan %A Chen, Keneng %A Chen, Jun %A Cui, Xiangli %A Fang, Wentao %A Gao, Shugeng %A Gilbert, Sebastien %A Fu, Jianhua %A Fu, Xiangning %A Hida, Yasuhiro %A Li, Shanqing %A Li, Xiaofei %A Li, Yin %A Li, Hecheng %A Li, Yongjun %A Liu, Deruo %A Liu, Lunxu %A He, Jianxing %A He, Jie %A Marulli, Giuseppe %A Oizumi, Hiroyuki %A de Perrot, Marc %A Petersen, René Horsleben %A Shargall, Yaron %A Sihoe, Alan %A Tan, Qunyou %A Wang, Qun %A Xu, Shun %A Yang, Mei %A Yang, Yuanhua %A Yu, Zhentao %A Zhang, Lanjun %A Zhang, Xun %A Zhao, Heng %A Zhi, Xiuyi %J Journal of Thoracic Disease %D 2018 %B 2018 %9 %! The Society for Translational Medicine: the assessment and prevention of venous thromboembolism after lung cancer surgery %K %X Cancer is an independent major risk factor for venous thromboembolism (VTE), which is the second leading cause of death in medically and surgically treated patients with cancer (1-5). The association between VTE and lung cancer has been reported more than 20 years ago (6,7). %U https://jtd.amegroups.org/article/view/21393 %V 10 %N 5 %P 3039-3053 %@ 2077-6624